Skip to content
Screener

Arcturus Therapeutics ARCT Q1 2026 earnings

Reported May 7, 2026 · After market close

Revenue$2.1MMiss by $4.2M
EPS-$0.95Beat by $0.06
Revenue estimate$6.3M
EPS estimate-$1.01

Next report

Nov 9, 2026 (in 2 months)
Revenue estimate$8.0M
EPS estimate-$0.67

FAQ

When did Arcturus Therapeutics report Q1 2026 earnings?
Arcturus Therapeutics (ARCT) reported Q1 2026 earnings on May 7, 2026 after market close.
What were Arcturus Therapeutics's Q1 2026 revenue and EPS?
Arcturus Therapeutics reported revenue of $2.1M and eps of $-0.95 for Q1 2026.
Did Arcturus Therapeutics beat estimates in Q1 2026?
Revenue missed the consensus estimate of $6.3M by $4.2M. EPS beat the consensus estimate of $-1.01 by $0.06.
How did Arcturus Therapeutics's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 93.0% from $29.4M a year earlier and eps declined 82.7% from $-0.52.
Where can I find Arcturus Therapeutics's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001193805-26-000573) and the 10-Q periodic report (0001193125-26-211943) directly on SEC EDGAR. The filing index links above go to sec.gov.